These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34015640)

  • 1. Positivity of oligoclonal bands in the cerebrospinal fluid predisposed to metabolic changes and rearrangement of inhibitory/excitatory neurotransmitters in subcortical brain structures in multiple sclerosis.
    Kantorová E; Hnilicová P; Bogner W; Grendár M; Čierny D; Hečková E; Strasser B; Ružinák R; Zeleňák K; Kurča E
    Mult Scler Relat Disord; 2021 Jul; 52():102978. PubMed ID: 34015640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive performance in relapsing-remitting multiple sclerosis patients is associated with metabolic abnormalities of the thalamus but not the hippocampus- GABA-edited 1H MRS study.
    Kantorová E; Hnilicová P; Bogner W; Grendár M; Grossmann J; Kováčová S; Hečková E; Strasser B; Čierny D; Zeleňák K; Kurča E
    Neurol Res; 2022 Jan; 44(1):57-64. PubMed ID: 34313578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early metabolic alterations in the normal‑appearing grey and white matter of patients with clinically isolated syndrome suggestive of multiple sclerosis: A proton MR spectroscopic study.
    Tzanetakos D; Kyrozis A; Karavasilis E; Velonakis G; Tzartos JS; Toulas P; Sotirli SA; Evdokimidis I; Tsivgoulis G; Potagas C; Kilidireas C; Andreadou E
    Exp Ther Med; 2023 Jul; 26(1):349. PubMed ID: 37324507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced MRI features in relapsing multiple sclerosis patients with and without CSF oligoclonal IgG bands.
    Zhao L; Abrigo J; Chen Q; Au C; Ng A; Fan P; Mok V; Qiu W; Kermode AG; Lau AY
    Sci Rep; 2020 Aug; 10(1):13703. PubMed ID: 32792656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered hypothalamic metabolism in early multiple sclerosis - MR spectroscopy study.
    Hnilicová P; Kantorová E; Poláček H; Grendár M; Bittšanský M; Čierny D; Sivák Š; Zeleňák K; Lehotský J; Dobrota D; Kurča E
    J Neurol Sci; 2019 Dec; 407():116458. PubMed ID: 31622679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.
    Ferreira D; Voevodskaya O; Imrell K; Stawiarz L; Spulber G; Wahlund LO; Hillert J; Westman E; Karrenbauer VD
    J Neuroimmunol; 2014 Sep; 274(1-2):149-54. PubMed ID: 24999245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis.
    Gaetani L; Bellomo G; Di Sabatino E; Sperandei S; Mancini A; Blennow K; Zetterberg H; Parnetti L; Di Filippo M
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnetic resonance findings in the brain of patients with multiple sclerosis without oligoclonal bands in the cerebrospinal fluid].
    Mesaroc S; Drulović J; Lević Z; Perić V
    Srp Arh Celok Lek; 2003; 131(1-2):31-5. PubMed ID: 14608859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid oligoclonal bands in Chinese patients with multiple sclerosis: the prevalence and its association with clinical features.
    Zhang X; Hao H; Jin T; Qiu W; Yang H; Xue Q; Yin J; Shi Z; Yu H; Ji X; Sun X; Zeng Q; Liu X; Wang J; Li H; He X; Yang J; Li Y; Liu S; Lau AY; Gao F; Hu S; Chu S; Ding D; Zhou H; Li H; Chen X
    Front Immunol; 2023; 14():1280020. PubMed ID: 38035077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude.
    Dobson R; Ramagopalan S; Davis A; Giovannoni G
    J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):909-14. PubMed ID: 23431079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients.
    Anagnostouli M; Christidi F; Zalonis I; Nikolaou C; Lyrakos D; Triantafyllou N; Evdokimidis I; Kilidireas C
    Neurol Sci; 2015 Nov; 36(11):2053-60. PubMed ID: 26130146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between obesity and oligoclonal band formation in multiple sclerosis patients.
    Çoban A; Çevik D; Özyurt S; Gencer M; Tüzün E; Türkoğlu R
    Obes Res Clin Pract; 2015; 9(5):533-5. PubMed ID: 26193825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS.
    Pardini M; Gualco L; Bommarito G; Roccatagliata L; Schiavi S; Solaro C; Mancardi G; Uccelli A; Capello E; Inglese M
    Mult Scler Relat Disord; 2019 Jun; 31():93-96. PubMed ID: 30953954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-voxel magnetic resonance spectroscopy of cerebral metabolites in healthy adults at 3 Tesla.
    Doelken MT; Mennecke A; Stadlbauer A; Kloska S; Struffert T; Engelhorn T; Thuerauf N; Doerfler A; Stefan H; Hammen T
    Acad Radiol; 2009 Dec; 16(12):1493-501. PubMed ID: 19781961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cortical lesion load and intrathecal inflammation is associated with oligoclonal bands in multiple sclerosis patients: a combined CSF and MRI study.
    Farina G; Magliozzi R; Pitteri M; Reynolds R; Rossi S; Gajofatto A; Benedetti MD; Facchiano F; Monaco S; Calabrese M
    J Neuroinflammation; 2017 Feb; 14(1):40. PubMed ID: 28222766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns.
    Huttner HB; Schellinger PD; Struffert T; Richter G; Engelhorn T; Bassemir T; Mäurer M; Garcia M; Schwab S; Köhrmann M; Doerfler A
    J Neurol; 2009 Jul; 256(7):1121-5. PubMed ID: 19252765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.
    Koch M; Heersema D; Mostert J; Teelken A; De Keyser J
    Eur J Neurol; 2007 Jul; 14(7):797-800. PubMed ID: 17594338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.
    Stich O; Kluge J; Speck J; Rauer S
    Acta Neurol Scand; 2015 Jun; 131(6):381-8. PubMed ID: 25402869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered in vivo brain GABA and glutamate levels are associated with multiple sclerosis central fatigue.
    Arm J; Oeltzschner G; Al-Iedani O; Lea R; Lechner-Scott J; Ramadan S
    Eur J Radiol; 2021 Apr; 137():109610. PubMed ID: 33657474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baló's concentric sclerosis is immunologically distinct from multiple sclerosis: results from retrospective analysis of almost 150 lumbar punctures.
    Jarius S; Würthwein C; Behrens JR; Wanner J; Haas J; Paul F; Wildemann B
    J Neuroinflammation; 2018 Jan; 15(1):22. PubMed ID: 29347989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.